The Fentanyl Crisis in San Joaquin County
The Fentanyl Crisis in San Joaquin County
LodiEye — July 2026
Overview
Over five years, San Joaquin County lived through the deadliest chapter of the drug epidemic, driven by one change: illicit fentanyl saturated the local supply. The county's fentanyl death rate in 2021 was 20 times higher than in 2018, and deaths more than doubled again the next year, from 48 in 2021 to 113 in 2022. At the peak, the county was losing four to five residents a week, and people in their 20s and early 30s died faster than any other age group.
In 2024 the county's opioid overdose rate finally dropped about 31 percent — the first sustained decline since the crisis began — helped by naloxone saturation, fentanyl test strips, and a $137 million treatment expansion. But three things complicate any relief. Methamphetamine now kills more Californians than any other single drug, and meth deaths are still rising as fentanyl deaths fall. A veterinary tranquilizer called xylazine is spreading up the West Coast toward the Central Valley. And in December 2024, Proposition 36 reversed a decade of California drug policy, restoring felony charges for repeat offenses just as the public-health approach began to work.
This report traces how the crisis rose and eased, who it hits hardest, how the drug supply chain reaches Lodi, what treatment and enforcement are doing, and what the open questions — from settlement spending to the methamphetamine gap — can and cannot yet be answered.
The Story So Far
Illicit fentanyl saturated the local drug supply starting around 2020. Fentanyl is roughly 50 times stronger than heroin and cheap to manufacture, so traffickers pressed it into counterfeit pills and laced it into heroin and fake prescription drugs. Statewide, fentanyl went from 3 percent of overdose deaths in 2013 to 51 percent by 2020. The fentanyl death rate climbed from 0.2 per 100,000 residents in 2013 to 18.3 by 2023.
California's Fentanyl Death Rate, 2013 vs. 2023
Source: World Forum for Mental Health, California Department of Public Health
San Joaquin County's fentanyl death rate in 2021 was 20 times higher than it had been in 2018. County fentanyl deaths more than doubled in one year, from 48 in 2021 to 113 in 2022. Opioids were a factor in 138 county deaths in 2021. At the peak, the county lost four to five residents a week to overdose. Lodi was among the harder-hit communities, and people in their 20s and early 30s died faster than any other age group.
San Joaquin County Fentanyl Deaths, 2021-2022
Source: San Joaquin County District Attorney's Office, Fentanyl Outreach Program
Then the curve bent. In 2024 the county's opioid overdose rate fell about 31 percent, from 23.8 to 16.31 per 100,000 residents — the first sustained decline since the crisis began. That mirrored a statewide drop of 26.2 percent between 2023 and 2024, the largest one-year decrease on record. California still recorded 9,028 overdose deaths in 2024, a rate 45 percent higher than in 2019.
San Joaquin County Opioid Overdose Rate, 2023-2024
Source: San Joaquin County Public Health, CDPH Overdose Surveillance Dashboard
The recovery arrived just as California reversed its criminal justice approach to drugs. Proposition 47 in 2014 had made simple drug possession a misdemeanor. Voters passed Proposition 36 in November 2024 with 68 percent support, restoring felony charges for repeat drug and theft offenses starting December 18, 2024. The county now runs a public health recovery and a renewed prosecution push at the same time.
Patterns of Use and Who Is at Risk
Drug use did not surge. The drugs got more lethal. Past-year narcotic use among high-school seniors fell to a record low of 1.7 percent, down from a peak of 9.5 percent. Fentanyl-related deaths among youth aged 10 to 19 jumped 113 percent in a single year. Fewer teenagers are experimenting, and those who do now risk a supply that can kill on the first try.
Teen Narcotic Use: Record Low vs. Peak Year
Source: Monitoring the Future, University of Michigan
Many victims were not chasing a high. They took what they believed was a real Percocet, Xanax, or oxycodone and died from a hidden dose of fentanyl. About 17 percent of Californians age 12 and older, roughly 5.6 million people, meet the criteria for a substance use disorder. Young adults aged 18 to 25 are affected at more than three times the adolescent rate.
Who Is Most Likely to Be Affected
| Risk Factor | Who Is Most Affected | What the Data Shows |
|---|---|---|
| Age | Men in their late 20s and 30s | More than half of county fentanyl deaths hit people aged 14-35; the county targets men 25-39 in its response |
| Race/ethnicity | Native American and Black residents | Both die at rates well above their population share; Black and Hispanic youth show the fastest recent increases |
| Sex | Males | Affected more than females across nearly every category |
| Circumstance | Unemployed people; sexual and gender minorities | Higher documented rates of misuse statewide |
| Intent | People who believe they're taking something safer | Most fatal overdoses are accidental |
Race and Ethnicity: Where the Trend Is Accelerating
California's opioid overdose death rate rose across every racial group between 2018 and 2023. American Indian and Alaska Native residents reached 52.4 deaths per 100,000 in 2023. Black residents reached 42.1. White residents reached 26.0. Hispanic residents reached 16.8. The Black rate climbed from 7.2 in 2018 to 42.1 in 2023, nearly a sixfold increase. San Joaquin County's own health data confirms the pattern: the Black and African American population is disproportionately affected, followed by American Indian and Alaska Native residents, then White residents.
California Opioid Death Rate by Race, 2018 vs. 2023
Source: KFF, State Health Facts, Drug Overdose Deaths by Race/Ethnicity
Which Substances Pose the Greatest Risk
Fentanyl is involved in about 91 percent of California opioid deaths. Its potency, roughly 50 times stronger than heroin, means a counterfeit pill can kill even when the buyer thinks it's a normal prescription. It increasingly reaches buyers through social media rather than street dealers.
Methamphetamine now appears in more California overdose deaths than any other single drug: 57 percent in 2024. The share of meth-involved deaths that also involved fentanyl quadrupled from 7 percent to 31 percent in a few years. Meth has no antidote comparable to naloxone.
Which Substances Drive California Overdose Deaths
Source: USAFacts, World Forum for Mental Health
How Associated Crime Varies by Substance
Methamphetamine correlates strongly with property and violent crime. In parts of northern California it has been linked to as much as 90 percent of burglaries, assaults, and domestic-violence incidents. Fentanyl and other opioids tie far more to overdose deaths, possession, and trafficking charges than to violence. Where methamphetamine dominates, the visible signs are break-ins and theft. Where fentanyl dominates, the toll is quieter and deadlier, measured in overdoses instead of police calls.
Meth Deaths Increasingly Also Involve Fentanyl
Source: USAFacts
The Supply Chain
The Central Valley sits at the crossroads of Interstate 5, Interstate 205, and State Route 99, making it a federally designated High Intensity Drug Trafficking Area. Arresting street dealers rarely slows supply, because they're the most replaceable link in the chain. Federal and state agencies now target leadership and money instead.
| Tier | Who They Are | What They Do | Documented Local Evidence |
|---|---|---|---|
| Source | Mexican transnational cartels | Manufacture and smuggle bulk fentanyl, meth, cocaine | Sinaloa-linked networks; 189 kilos of cocaine tracked from the border; in-Valley meth conversion labs |
| Wholesale | Cartel-connected distribution cells | Move product regionally, sometimes directed from prison | 2025 federal indictment charging 14 in a meth conspiracy, including a Lodi resident |
| Distribution | Street and prison gangs | Handle neighborhood sales; tax other dealers | Norteno-Sureno rivalry; East Side Crips; Southeast Asian gangs |
| Retail | Individual street dealers | Sell directly to users | Local sweeps such as Operation Folsom Blues |
Treatment and Prevention
San Joaquin County Behavioral Health Services coordinates all public drug and alcohol treatment and won a $137 million state grant in 2025 to expand capacity. The system offers medically supervised detox, residential beds, outpatient counseling, and medication-assisted treatment using drugs like buprenorphine, the medical standard for opioid addiction.
Lodi residents can access care through Adventist Health Lodi Memorial, Aegis Treatment Centers, and Towns Health Services. Countywide, detox beds exist in French Camp, culturally specific programs serve Native American clients in Manteca, and a 24-hour line connects residents to intake anytime.
County Public Health distributes naloxone and fentanyl test strips through its offices, a mobile van, and vending machines that run around the clock. Naloxone is also sold without a prescription at pharmacies. Collaborative and drug courts offer treatment instead of incarceration for eligible defendants.
Capacity strain ahead: Proposition 36 adds court-mandated clients competing for the same treatment slots as voluntary patients. Under the original 2000 version of the law, a third of providers reported reduced capacity for non-mandated clients. The new $137 million grant may determine whether the county can serve both groups.
Enforcement
Federal agencies run the Organized Crime Drug Enforcement Task Force, targeting trafficking leadership and finances through asset forfeiture. A regional Central Valley HIDTA program gave local departments $4.7 million in 2024. State agencies run gang-suppression operations through the DOJ's Bureau of Narcotic Enforcement. Locally, the Metro Narcotics Task Force, the District Attorney's fentanyl team, the DA's Gang Violence Suppression Unit, and the Lodi Police Special Investigations Unit each handle a piece of enforcement.
Proposition 36's real test is whether it delivers treatment or just more jail time. Of roughly 9,000 people charged statewide in its first months, only 15 percent chose treatment. Just 771 were placed in a program, and 25 completed one.
Proposition 36: From Charges to Treatment Completion
Source: CalMatters, California Department of Justice
The law passed with no dedicated funding: a one-time $100 million against bipartisan requests for $600 million a year. That funding gap explains the steep drop-off between charges and completed treatment.
Why the Crisis Is Easing, With Caveats
The decline reflects several forces at once: naloxone saturation, wide fentanyl test-strip distribution, expanded treatment funding, and a maturing illicit market. Two cautions apply. The 2024 and 2025 numbers are provisional and may rise as toxicology results finalize. And methamphetamine's climb to the top of the overdose list means the danger is changing shape, not going away — stimulants have no naloxone equivalent.
The 2025-2026 Picture
The decline held. Nationally, 2025 brought the lowest 12-month overdose death total since at least 2019 — 69,973 deaths in the year ending December 2025, roughly 11,300 fewer than 2024 and down sharply from the summer-2023 peak of 112,418. It is the longest sustained drop in more than 40 years. Opioid deaths kept falling through 2025, and for the third straight year fentanyl seizures dropped, down 28.6 percent from 2023. Analysts partly credit a less potent illicit fentanyl supply for the falling toll.
US Overdose Deaths: 2023 Peak vs. Latest (12-Month Totals)
Source: CDC NVSS provisional 12-month counts, data as of June 2026; Dec 2025 figure provisional and subject to upward revision
Two warnings sit inside the good news, and both point at California. First, the improvement is uneven: while most of the country improved, several Western states reported rising overdoses in 2025, with officials in New Mexico blaming "stronger fentanyl and tranquilizers" — the same xylazine-and-fentanyl combination spreading up the West Coast toward the Central Valley. Second, the 2025 and 2026 figures are provisional, and the CDC expects them to be revised upward as reporting completes, so the final improvement may look somewhat smaller. Caveat: these are national and Western-state numbers. San Joaquin County has not yet published its own 2025 or 2026 overdose figures, so whether the local curve tracked the national decline or the Western-state exception is not yet knowable from public data.
Emerging Threat: Xylazine
A third substance is spreading toward California from the East Coast: xylazine, a veterinary tranquilizer known on the street as "tranq." No published county-specific data confirms or rules out xylazine in San Joaquin County's drug supply, and that gap itself is worth flagging.
The California Department of Public Health has tracked xylazine since 2023 and says there is "no evidence to suggest that xylazine is common in California's drug supply," while warning trafficking patterns can shift fast. Confirmed detections have already turned up in Los Angeles, San Francisco, San Diego, and Santa Clara counties. A UC San Diego study found xylazine in over 80 percent of tested drug-user samples in Tijuana. A 2025 lab study of the Los Angeles fentanyl supply found a significantly increasing prevalence of xylazine arriving in West Coast markets. Stockton's own congressional representative, Josh Harder, urged the DEA in 2024 to classify xylazine as a controlled substance.
How a Xylazine Overdose Differs From a Fentanyl Overdose
Both drugs slow or stop breathing, cause unconsciousness, lower blood pressure, and constrict pupils, which makes the two hard to tell apart. A few signs point specifically to xylazine: naloxone restores breathing but the person stays unconscious, because naloxone only reverses the opioid component; severe, necrotic skin wounds appear far from any injection site; blood sugar rises and the mouth goes dry, symptoms fentanyl alone doesn't cause; and withdrawal can bring chest pain and seizures.
Naloxone can't reverse xylazine's sedation, but health authorities still recommend giving it in any suspected overdose, because xylazine is almost never used alone and naloxone will still treat the opioid part. Give naloxone, call 911, and continue rescue breathing regardless of whether xylazine is suspected.
Answering the Open Questions
Several questions sit at the edge of the published data. The table below gives the one-line answer and how confident the evidence lets us be; the detail and caveats follow.
| Question | Short Answer | Confidence |
|---|---|---|
| Where is the settlement money going? | ~$53M over 8-15 years, centered on the SJ Be Well Campus; $1.96M spent in FY 2023-24 | High on totals and plan; medium on year-by-year line items |
| Do schools stock naloxone and teach fentanyl awareness? | Melanie's Law requires overdose plans and staff training for grades 7-12; stocking is encouraged, not mandated | High on the statewide mandate; low on which local campuses actually stock it |
| How closely does substance use track with suicide? | They cluster in the same people and places, but the link is correlation, not proven causation | Medium; co-occurrence is documented, causation is not |
| What does the crisis cost? | Roughly $165M in lost productivity from 2022 fentanyl deaths alone; hundreds of millions a year overall | Low-to-medium; an extrapolation from national averages, not a local audit |
| What is being done about methamphetamine? | Contingency management via California's Recovery Incentives Program, the only strong evidence-based option | High on the program and evidence; low on local enrollment |
Where the settlement money is going
San Joaquin County expects roughly $53 million from the national opioid settlement, paid out over 8 to 15 years as drug makers and pharmacies resolve the litigation brought against them. The Board of Supervisors was presented a strategic abatement plan in August 2023, and the centerpiece is the SJ Be Well Campus — a one-stop treatment complex on county-owned land in French Camp, built in two phases. Phase one includes a dual-diagnosis point of entry, a sobering center, medical detox, a psychiatric health facility, and a crisis stabilization unit. Phase two adds transitional residential cottages, expanded perinatal programming, a youth residential treatment facility, and youth aftercare outpatient programs.
The money is not unrestricted. Under the national settlement terms, at least 50 percent of what the county receives in a calendar year must go to "high-impact abatement activities" — direct treatment, prevention, and recovery services rather than administration. The county's actual reported spending is now visible in state filings: San Joaquin County reported $1,961,829 in settlement expenditures in the 2023-2024 state fiscal year, up sharply from near zero the year before, a jump the state attributes to the shift from planning into active spending. Caveat: the total, the abatement plan, and the annual expenditure figures are public, but a full line-item breakdown of exactly how each dollar split across prevention, treatment, and harm reduction is filed in the county's individual DHCS reports rather than consolidated into one public dashboard, and the Be Well Campus construction timeline has not been confirmed complete.
Whether schools stock naloxone and teach fentanyl awareness
California tightened its school rules in a single legislative push. Governor Newsom signed three bills in 2023 — SB 10, AB 889, and SB 234 — all aimed at opioid overdoses in schools. The most important is SB 10, named Melanie's Law after a teenager who died of a fentanyl overdose. Effective January 1, 2024, it requires every school serving grades 7 through 12 to write opioid-overdose protocols directly into its Comprehensive School Safety Plan, including how staff respond to an overdose and how they are trained to use naloxone.
The distinction that matters is between "must plan" and "must stock." Before Melanie's Law, California only authorized schools to decide for themselves whether to keep emergency naloxone on hand. Melanie's Law makes the planning and training mandatory, and the state removes the cost barrier by supplying naloxone free through its Naloxone Distribution Project, which any school can enroll in. Caveat: the training and safety-plan mandate is statewide and enforceable, but physically stocking naloxone at every campus remains authorized rather than strictly required, so actual possession still varies by district. Confirming exactly which San Joaquin County and Lodi Unified schools keep naloxone on site, how many doses, and how many staff are trained would require a records request to those districts — the state law guarantees the plan exists, not the supply on every shelf.
How closely substance use tracks with suicide
Substance use and suicide overlap heavily in the San Joaquin Valley, but the relationship is more tangled than a simple cause and effect. The county's Community Health Needs Assessment found residents experience more days of poor mental health per month and higher rates of suicide, drug overdose, and alcohol-related death than the California average. The county treats the connection seriously enough to maintain a standalone Suicide Prevention Plan built through a community process that deliberately included substance-use providers alongside mental-health providers.
National research published in 2025 sharpens the picture. Studying overdose and suicide as a possible "syndemic" — two epidemics feeding each other — researchers found that neighborhoods with overdose spikes showed contemporaneously elevated suicide rates in the same period. But the same study found overdose spikes generally did not predict later suicide rates, and it stopped short of calling the link robust. Caveat: this is the crucial nuance. The two problems cluster in the same people, places, and moments, which makes combined prevention sensible, but the evidence shows correlation, not proof that one drives the other. Some overdose deaths are also themselves undetermined between accident and suicide, which blurs the line the statistics try to draw. A county-specific figure for how many overdose deaths involve documented suicidal intent is not published and would require coroner-level record review.
What the crisis costs
No agency publishes a San Joaquin County-specific price tag, but national per-case figures let us build a grounded estimate. The CDC's state-level analysis put the cost of a single fatal opioid overdose at roughly $1.45 million in lost lifetime productivity plus about $5,500 in health care, in 2017 dollars. The productivity figure dominates because most overdose victims are young and working-age — the calculation counts the decades of earnings a person would have produced had they lived.
Applied locally, the scale becomes concrete. The county's 113 fentanyl deaths in 2022 alone imply roughly $165 million in lost productivity for that single year of deaths — and that counts only fentanyl, only deaths, and only one year. It leaves out the county's methamphetamine and other opioid deaths, the far larger number of nonfatal overdoses, the ambulance runs, the emergency-room and hospital stays, the naloxone deployments, the child-welfare cases, and the jail and court costs. National accounting shows just how large those excluded categories are: patients who survive an overdose account for nearly $2 billion in annual U.S. hospital costs, and the crisis added an estimated $107 billion in health-care system costs in 2023. Caveat: the local figure is an extrapolation from national averages, not a county audit. Real per-case costs vary with local wages, health-care prices, and life expectancy, so this is best read as an order-of-magnitude signal of the loss — comfortably in the hundreds of millions of dollars a year — not a precise budget line.
What is being done about methamphetamine
Methamphetamine is now the harder half of the crisis to fight, and the data explains why. Statewide, psychostimulant deaths — overwhelmingly methamphetamine — rose 152 percent between 2018 and 2023, from 2,427 to 6,127 deaths, and meth now contributes to 54 percent of all California overdose deaths. A UC San Diego study published in June 2026 found the reason the overall crisis eased in 2024 was falling fentanyl deaths. Meth-only deaths, by contrast, kept rising, from 18,142 to 18,907 nationally, growing from 17.3 percent of overdose deaths to 23.8 percent. The researchers warned that if the trend holds, stimulants could soon overtake opioids as the country's defining addiction problem. Methamphetamine deaths also fall hardest on American Indian and Alaska Native communities, the same group carrying the highest overall overdose rate.
Meth Deaths Keep Rising as Fentanyl Deaths Fall (US, 2023-2024)
Source: UC San Diego, journal Addiction, June 2026
The problem is that meth has no medication equivalent to buprenorphine, which treats opioid addiction, or naloxone, which reverses opioid overdose. There is no pill to prescribe and no shot to reverse a meth overdose in progress. So California turned to the one approach with the strongest evidence: contingency management, which pays patients small gift-card incentives — up to $599 a year — for submitting drug-free urine tests. The method rewards abstinence directly, and more than 100 studies over several decades make it the most effective treatment for stimulant use disorder. In a Veterans Health Administration study of nearly 3,000 patients, those who received contingency management were 41 percent less likely to die within a year than those who did not.
California became the first state to cover contingency management as a Medi-Cal benefit through its Recovery Incentives Program. Patients diagnosed with moderate or severe stimulant use disorder receive 24 weeks of twice-weekly testing with escalating rewards. By early 2024, 70 treatment sites across 15 counties had begun offering the service, part of a pilot approved for 24 counties covering most of the state's Medi-Cal population. Caveat: the state's approved-county list and program design are public, but they do not confirm San Joaquin County's specific participation status or local enrollment numbers, which would need to come from county Behavioral Health Services directly. Early state evaluations also caution that enrollment started small — just 156 people statewide in the first months — and completion data for the full 24-week program was not yet available at the last published report.
LodiEye is the original civic-reporting and analysis arm of Lodi411.com, a citizen-run civic data and transparency platform serving Lodi, California and San Joaquin County. LodiEye gathers information of public interest, applies editorial judgment to public records, meetings, and data, and publishes original explanatory reporting for its readers — the work of a newsroom, and a representative of the news media as that term is defined under federal law. Our reporting emphasizes primary sources, public data, and full source transparency so readers can check every claim. LodiEye complements, and does not replace, the other outlets covering this region; for additional reporting on Lodi, San Joaquin County, and the broader region, we also encourage readers to consult the Lodi News-Sentinel, Stocktonia, The Sacramento Bee, CalMatters, and other established news organizations. Our full editorial standards and news-media-status statement is published at lodi411.com/editorial-standards.
This LodiEye report was produced using artificial intelligence tools under the direction and review of the founder. Lodi411 uses multiple AI platforms in its research and publication workflow, including Anthropic's Claude (primarily Opus and Sonnet models) and Perplexity AI across a variety of large language models offered by each. These tools were used in the following capacities:
Source Discovery: AI-assisted search identified more than 100 sources, including San Joaquin County Public Health and District Attorney data, California Department of Public Health surveillance figures, KFF state health statistics, peer-reviewed toxicology research, and DEA and federal court filings. Perplexity AI handled initial source discovery and real-time data retrieval; Claude conducted deeper analysis of identified sources.
Credibility Validation: AI cross-referenced death-rate figures, arrest data, and treatment statistics across multiple independent sources, prioritizing government health surveillance data, court and law-enforcement records, and peer-reviewed research over news commentary. Multiple AI models independently verified key statistics, including county fentanyl death counts and Proposition 36 completion rates.
Analysis and Synthesis: Claude Opus and Sonnet assisted in organizing the county's overdose trend into a coherent timeline, identifying the demographic risk factors most supported by the data, and mapping the four-tier drug supply chain from cartels to street dealers.
Presentation: Claude assisted in drafting section structure, data tables, and chart selection, including the race/ethnicity death-rate comparison, the Proposition 36 outcome funnel, and the substance-involvement breakdown.
Final Review: Multiple AI models reviewed the completed draft for factual consistency, source attribution accuracy, and balanced presentation across enforcement, treatment, and public-health perspectives. Throughout the process, the editor set the report's goals, scope, and tone; shaped and revised the draft content; reviewed the AI cross-checks; and made the final editorial decisions.
Lodi411/LodiEye believes that transparency about how our research is produced, including our use of AI under human direction, strengthens trust with readers and the broader information ecosystem. Readers who spot an error are encouraged to write editor@lodi411.com so we can correct it.